Innova Captab Ltd (NSE:INNOVACAP) Share Price

Company Profile

Business description
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
Contact
Plot No.320
Industrial Area, Phase-1
PanchkulaHR134113
IND
T: +91 1724194500
https://www.innovacaptab.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
2,298

Recommended

Real estate share remains cheap despite losing airport legal battle.

Yingqi Tan, CFA | 12 June 2026

The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.

Jacob Robbins | 11 June 2026

We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.

Seth Goldstein, CFA | 11 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,006.10	29.10	0.32%
CAC 40	8,350.87	150.08	1.83%
DAX 40	24,635.30	425.59	1.76%
Dow JONES (US)	51,137.40	288.65	0.57%
FTSE 100	10,471.72	167.84	1.63%
HKSE	24,718.10	468.81	1.93%
NASDAQ	25,838.61	28.95	0.11%
Nikkei 225	66,020.04	1,802.77	2.81%
NZX 50 Index	13,393.87	191.71	1.45%
S&P 500	7,418.11	23.81	0.32%
S&P/ASX 200	8,804.00	30.50	0.35%
SSE Composite Index	4,031.51	44.50	1.12%